Skip to content

Contribution of Narrow Band Imaging (NBI) for the Characterization of Scalloped Polyps (NBI POLYPES COLIQUES)

Contribution of Narrow Band Imaging (NBI) for the Characterization of Scalloped Polyps

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03448653
Enrollment
314
Registered
2018-02-28
Start date
2018-07-09
Completion date
2022-07-12
Last updated
2024-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polyps of Colon

Brief summary

This prospective bicentric trial aims to evaluate the diagnostic performance of the characterization of scalloped polyps less than 20 millimeter in NBI (Narrow Band Imaging) in patients with screening colonoscopy. The NBI is a so-called virtual electronic staining technique available on conventional OLYMPUS endoscopes without additional intervention. The colonoscopy procedure for each patient will not be different from a conventional colonoscopy examination with excision of all polyps visualized and anatomopathological analysis, except for a short time of analysis in NBI for each polyp detected before excision to classify the polyp in existing endoscopic classifications (ie NICE classification for adenomatous polyps and WASP classification for festooned polyps).

Interventions

OTHERColonoscopy with NBI

Colonoscopy with NBI

Sponsors

Centre Hospitalier Departemental Vendee
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Pre-inclusion criteria: * Major patient with a colonoscopy scheduled in one of the participating hospitals (CHD Vendée and CHU Nantes). * Patient who agreed to participate in the study and gave his express consent * Patient affiliated with a social security system or beneficiary of a scheme Inclusion Criteria: * Patient with 1 or more polyps less than 20 mm observed during colonoscopy

Exclusion criteria

* Patient with an emergency colonoscopy for ongoing digestive bleeding or occlusion symptoms * Patient with chronic inflammatory bowel disease (IBD): Crohn's disease or unclassified colitis * Patient with familial adenomatous polyposis * Pregnant or lactating woman * Minor patient * Major patient under tutorship, curatorship, or deprived of liberty * Patient unable to understand protocol and / or give express consent * Patient not affiliated with a social security system or beneficiary of such a scheme * Patient hospitalized or treated without their consent

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of the NBI Compared to the Anatomopathological Analysis (= Reference Method)An average of 1 monthNumber of polyps characterized as scalloped (NICE II-) by NBI relative to the number of polyps characterized as scalloped in standard histology

Countries

France

Participant flow

Participants by arm

ArmCount
Colonoscopy With NBI
Colonoscopy with NBI: Colonoscopy with NBI
312
Total312

Baseline characteristics

CharacteristicColonoscopy With NBI
Age, Continuous67 years
STANDARD_DEVIATION 9
Ethnicity (NIH/OMB)
Hispanic or Latino
NA Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
NA Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
312 Participants
Region of Enrollment
France
312 participants
Sex: Female, Male
Female
117 Participants
Sex: Female, Male
Male
195 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Sensitivity of the NBI Compared to the Anatomopathological Analysis (= Reference Method)

Number of polyps characterized as scalloped (NICE II-) by NBI relative to the number of polyps characterized as scalloped in standard histology

Time frame: An average of 1 month

Population: All polyps with histological analysis available in eligible patients

ArmMeasureValue (NUMBER)
Colonoscopy With NBISensitivity of the NBI Compared to the Anatomopathological Analysis (= Reference Method)0.844 proportion of positive cases

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026